אולנזאפין דקסל 5 מ"ג

Maa: Israel

Kieli: heprea

Lähde: Ministry of Health

Aktiivinen ainesosa:

OLANZAPINE 5 MG

Saatavilla:

DEXCEL PHARMA TECHNOLOGIES LTD

ATC-koodi:

N05AH03

Lääkemuoto:

TABLETS

Antoreitti:

PER OS

Valmistaja:

DEXCEL LTD

Terapeuttinen ryhmä:

OLANZAPINE

Käyttöaiheet:

Acute and maintenance treatment of schizophrenia. Olanzapine is indicated for the management of the manifestations of psychotic disorders. Olanzapine is indicated for the short-term treatment of acute manic episodes associated with Bipolar I Disorder. Prevention of recurrence in Bipolar Disorder: in patients whose manic episodes has responded to olanzapine treatment, olanzapine is indicated for the prevention of recurrence in patients with Bipolar Disorder. Combination therapy in Bipolar I Disorder: the combination of olanzapine with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with Bipolar I Disorder.

Valtuutus päivämäärä:

2012-05-01